+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Table of Contents
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Alzheimers Disease Diagnostic MARKET, BY Type
6.1. Overview
6.2. Early Onset Alzheimers
6.3. Late Onset Alzheimers
6.4. Familial Alzheimers Disease
6.5. Others
7. GLOBAL Alzheimers Disease Diagnostic MARKET, BY Diagnostic Tests
7.1. Overview
7.2. Genetic Testing
7.3. Neurological Exam
7.4. Mini Mental State Exam (MMSE)
7.5. Brain Imaging
7.6. Others
8. GLOBAL Alzheimers Disease Diagnostic MARKET, BY End-use
8.1. Overview
8.2. Clinic
8.3. Hospita
8.4. Diagnostic Center
8.5. Others
9. GLOBAL Alzheimers Disease Diagnostic MARKET, by Region
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. South Korea
9.4.5. Australia
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. Competitive Landscape
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Alzheimers Disease Diagnostic Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Alzheimers Disease Diagnostic Market,
10.7. Key developments and Growth Strategies
10.7.1. New Type Launch/Diagnostic Tests Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. Company ProfileS
11.1. Eli Lilly and Company
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Types Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. TauRx (Republic of Singapore)
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Types Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Alector LLC
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Types Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Accera, Inc.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Types Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Treventis Corporation
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Types Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. NEURO-BIO LTD
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Types Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Cognition Therapeutics Inc
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Types Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Hoffmann-La Roche
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Types Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Novartis AG
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Types Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Merck & Co.
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Types Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Pfizer Inc.
11.11.1. Company Overview
11.11.2. Financial Overview
11.11.3. Types Offered
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Allergan PLC
11.12.1. Company Overview
11.12.2. Financial Overview
11.12.3. Types Offered
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Daiichi Sankyo Co.
11.13.1. Company Overview
11.13.2. Financial Overview
11.13.3. Types Offered
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
12. Appendix
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 Global Alzheimers Disease Diagnostic Market, Synopsis, 2018-2032
TABLE 2 Global Alzheimers Disease Diagnostic Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 6 North America Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 7 North America Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 8 North America Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 9 North America Alzheimers Disease Diagnostic MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 10 U.S. Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 11 U.S. Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 12 U.S. Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 13 Canada Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 14 Canada Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 15 Canada Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 16 Europe Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 17 Europe Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 18 Europe Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 19 Europe Alzheimers Disease Diagnostic MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 20 Germany Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 21 Germany Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 22 Germany Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 23 France Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 24 France Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 25 France Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 26 Italy Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 27 Italy Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 28 Italy Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 29 Spain Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 30 Spain Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 31 Spain Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 32 U.K Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 33 U.K Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 34 U.K Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 35 Rest of Europe Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 36 Rest of Europe Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 37 Rest of Europe Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 38 Asia Pacific Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 39 Asia Pacific Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 40 Asia Pacific Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 41 Asia Pacific Alzheimers Disease Diagnostic MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 42 Japan Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 43 Japan Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 44 Japan Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 45 China Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 46 China Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 47 China Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 48 India Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 49 India Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 50 India Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 51 Australia Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 52 Australia Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 53 Australia Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 54 south korea Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 55 south korea Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 56 south korea Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 57 Rest of asia-pacific Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 58 Rest of asia-pacific Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 59 Rest of asia-pacific Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 60 Rest of WOrld Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 61 Rest of WOrld Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 62 Rest of WOrld Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 63 Rest of WOrld Alzheimers Disease Diagnostic MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 64 Middle east Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 65 Middle east Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 66 Middle east Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 67 Africa Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 68 Africa Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 69 Africa Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
TABLE 70 Latin america Alzheimers Disease Diagnostic MARKET, BY Type, 2018-2032 (USD BILLION)
TABLE 71 Latin america Alzheimers Disease Diagnostic MARKET, BY DIAGNOSTIC TESTS, 2018-2032 (USD BILLION)
TABLE 72 Latin america Alzheimers Disease Diagnostic MARKET, BY END-USE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Alzheimers Disease Diagnostic Market
FIGURE 3 Market Dynamics for the Global Alzheimers Disease Diagnostic Market
FIGURE 4 Global Alzheimers Disease Diagnostic Market, Share (%), BY Type, 2022
FIGURE 5 Global Alzheimers Disease Diagnostic Market, Share (%), BY DIAGNOSTIC TESTS, 2022
FIGURE 6 Global Alzheimers Disease Diagnostic Market, Share (%), BY END-USE, 2022
FIGURE 7 Global Alzheimers Disease Diagnostic Market, Share (%), by Region, 2022
FIGURE 8 north AMERICA: Alzheimers Disease Diagnostic MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 Europe: Alzheimers Disease Diagnostic MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Asia-Pacific: Alzheimers Disease Diagnostic MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Rest of the world: Alzheimers Disease Diagnostic MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Global Alzheimers Disease Diagnostic Market: Company Share Analysis, 2022 (%)
FIGURE 13 Eli Lilly and Company: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 Eli Lilly and Company: SWOT ANALYSIS
FIGURE 15 TauRx (Republic of Singapore): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 TauRx (Republic of Singapore): SWOT ANALYSIS
FIGURE 17 Alector LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 Alector LLC: SWOT ANALYSIS
FIGURE 19 Accera, Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 Accera, Inc.: SWOT ANALYSIS
FIGURE 21 Treventis Corporation.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 Treventis Corporation.: SWOT ANALYSIS
FIGURE 23 NEURO-BIO LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 NEURO-BIO LTD: SWOT ANALYSIS
FIGURE 25 Cognition Therapeutics Inc: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 Cognition Therapeutics Inc: SWOT ANALYSIS
FIGURE 27 Hoffmann-La Roche: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 Hoffmann-La Roche: SWOT ANALYSIS
FIGURE 29 Novartis AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 Novartis AG: SWOT ANALYSIS
FIGURE 31 Merck & Co.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 Merck & Co.: SWOT ANALYSIS
FIGURE 33 Pfizer Inc.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 Pfizer Inc.: SWOT ANALYSIS
FIGURE 35 Allergan PLC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 Allergan PLC.: SWOT ANALYSIS
FIGURE 37 Daiichi Sankyo Co.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 Daiichi Sankyo Co.: SWOT ANALYSIS
Report Code :
RL6538
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst